Recursion Pharmaceuticals (RXRX): Industrializing Drug Discovery with AI Amid J.P. Morgan’s ‘Neutral’ Outlook

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a look at where Recursion Pharmaceuticals (NASDAQ:RXRX) stands against the ...

Silicon Valley Wants to Build A.I. That Can Improve A.I. on Its Own

Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to ...

MIT’s new ‘recursive’ framework lets LLMs process 10 million tokens without context rot

While standard models suffer from context rot as data grows, MIT’s new Recursive Language Model (RLM) framework treats ...
IEEE

Outlier-Aware Recursive Instantaneous Minimum Error Entropy Algorithm

Abstract: The minimum error entropy (MEE) criterion closely relies on the quadratic information potential (QIP) estimates of Renyi’s entropy. Nevertheless, the ...
GitHub

A recursive, reflective POETRY algorithm variant using Goedel-Prover-V2

Gödel's Poetry is an advanced automated theorem proving system that combines Large Language Models (LLMs) with formal verification in Lean 4. The system takes mathematical theorems—either in informal ...
IEEE

Stochastic Analysis of Regularized Recursive Least-Squares Algorithm

Abstract: The regularized recursive least-squares (RLS) algorithm with an appropriate regularization parameter has much better robustness performance than the regular RLS algorithm in the presence of ...
Nasdaq

Forget Recursion Pharmaceuticals Stock. This Is a Much Better Buy.

Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.